Asialoglycoprotein Receptor-Targeted Superparamagnetic Perfluorooctylbromide Nanoparticles

BACKGROUND: The decrease in asialoglycoprotein receptor (ASGPR) levels is observed in patients with chronic liver disease and liver tumor. The aim of our study was to develop ASGPR-targeted superparamagnetic perfluorooctylbromide nanoparticles (M-PFONP) and wonder whether this composite agent could...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Yang, Chao Feng, Zuo, Hui, Li, Ao, Das, Sushant Kumar, Yu, Jin Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181107/
https://www.ncbi.nlm.nih.gov/pubmed/34131415
http://dx.doi.org/10.1155/2021/5510071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181107/
https://www.ncbi.nlm.nih.gov/pubmed/34131415
http://dx.doi.org/10.1155/2021/5510071

Ejemplares similares